Georgia CommonsHB 334: Sickle Cell Disease Protection Act; enact
Última acción: 5 de mayo de 2026 · Effective Date 2026-07-01
Georgia House Bill 334 would require child care centers to give parents yearly information on RSV and require the Department of Community Health to review Medicaid coverage for sickle cell disease treatments every year.
Los resúmenes de abajo son traducciones de resúmenes en inglés escritos por un modelo de IA (claude-sonnet-5) a partir del texto del proyecto de ley; no forman parte de él. El proyecto de ley está en inglés. Cite el texto, no el resumen. El texto almacenado es la versión Enrolled, la más reciente que tiene LegiScan.
El resumen en español de este proyecto de ley se está preparando. Mientras tanto se muestra el resumen en inglés.
En lenguaje claro
This bill addresses two separate health issues in Georgia law. First, it amends the state's early care and learning code (O.C.G.A. § 20-1A-18) so that every child care learning center and family child care learning home must give parents or guardians educational information about respiratory syncytial virus (RSV) and prevention recommendations by September 1 each year, based on guidance from groups like the American Academy of Pediatrics. Second, it adds a new section to Georgia's public assistance code (O.C.G.A. § 49-4-159.5) requiring the Department of Community Health to review, every year, all medications, treatments, and services covered by Medicaid for people diagnosed with sickle cell disease. The department must seek public input, especially from people or groups experienced with sickle cell disease treatment, and must submit a report to legislative leaders by January 15 each year and post it on its website.
Qué hace el proyecto de ley
- Requires child care learning centers and family child care learning homes to give parents yearly written information on RSV and prevention by September 1.
- Bases the RSV information on guidelines from professional medical organizations such as the American Academy of Pediatrics.
- Creates a new requirement for the Department of Community Health to review Medicaid-covered medications, treatments, and services for sickle cell disease patients every year.
- Requires the department to gather public input on the annual review, with special focus on people experienced in sickle cell disease treatment.
- Requires an annual report to the General Assembly's presiding officers and relevant committees by January 15, plus public posting of the report online.
A quién afecta
Parents and guardians of children enrolled in Georgia child care centers and family child care homes, child care providers who must distribute the RSV information, Medicaid recipients diagnosed with sickle cell disease, and the Department of Community Health, which must conduct the reviews and submit reports.
Por qué importa
Families using licensed child care would get yearly RSV prevention information they may not currently receive. Medicaid patients with sickle cell disease could see more attention paid to whether their treatment options are adequate, since the state would have to formally review coverage and report findings each year.
Disposiciones clave
- Section 1 adds subsection (a.1) to O.C.G.A. § 20-1A-18, requiring child care providers to give RSV information to parents by September 1 annually.
- Section 2 creates O.C.G.A. § 49-4-159.5, requiring an annual Department of Community Health review of Medicaid coverage for sickle cell disease medications, treatments, and services.
- Section 2(b) requires the department to solicit public input during the review, emphasizing input from those with sickle cell disease treatment experience.
- Section 2(c) requires a report to the General Assembly's presiding officers and standing committees by January 15 each year, and requires the report be published on the department's website.
- Section 3 repeals any conflicting laws.
Del proyecto de ley
“Each child care learning center and family child care learning home shall, by September 1 of each year, provide to the parent or guardian of each child enrolled therein educational information on the respiratory syncytial virus (RSV) and recommendations on prevention”
“The department shall conduct an annual review of all medications, forms of treatment, and services that are eligible for coverage under the Medicaid program for Medicaid recipients with a diagnosis of sickle cell disease.”
Cronología del estado
- Effective Date 2026-07-01
- Act 401
- House Date Signed by Governor (Cámara de Representantes)
- House Sent to Governor (Cámara de Representantes)
- House Agreed Senate Amend or Sub (Cámara de Representantes)
- Senate Passed/Adopted By Substitute (Senado)
- Senate Third Read (Senado)
- Senate Taken from Table (Senado)
Mostrar el historial completo (20 acciones)
- Senate Tabled (Senado)
- Senate Read Second Time (Senado)
- Senate Committee Favorably Reported By Substitute (Senado)
- Senate Read and Referred (Senado)
- House Passed/Adopted (Cámara de Representantes)
- House Third Readers (Cámara de Representantes)
- House Postponed (Cámara de Representantes)
- House Postponed (Cámara de Representantes)
- House Committee Favorably Reported (Cámara de Representantes)
- House Second Readers (Cámara de Representantes)
- House First Readers (Cámara de Representantes)
- House Hopper (Cámara de Representantes)
Patrocinadores
- Omari Crawford (D, HD-089)
- Mary Oliver (D, HD-084)
- Michelle Au (D, HD-050)
- Inga Willis (D, HD-055)
- Anne Westbrook (D, HD-163)
- Edna Jackson (D, HD-165)
- Ed Harbison (D, SD-015)
Votaciones
- Votación: Cámara de Representantes6 de marzo de 2026
159 a favor, 7 en contra (2 sin votar, 9 ausentes)
- Votación: Senado31 de marzo de 2026
39 a favor, 10 en contra (2 sin votar, 3 ausentes)
- Votación: Senado2 de abril de 2026
49 a favor, 0 en contra (4 sin votar, 1 ausentes)
- Votación: Cámara de Representantes2 de abril de 2026
149 a favor, 18 en contra (6 sin votar, 3 ausentes)
Temas
- sickle cell disease
- Medicaid coverage
- child care regulations
- RSV prevention
- public health